Mikael Dolsten News
Most Popular Mikael Dolsten Story
Pfizer/Wyeth merger could eliminate $3B, R&D jobs
In an interview with Bloomberg, Pfizer R&D chief Martin Mackay said the company could cut billions in R&D costs as it combines its laboratory operations with Wyeth's in the wake of their Read more...
Latest Headlines
- April 1, 2011
- February 1, 2011
- September 14, 2010
- October 15, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
